Dr. Nicole Lamanna serves as Professor of Medicine and Director of the Chronic Lymphocytic Leukemia (CLL) Program on the Leukemia Service for the Hematologic Malignancies Section in the Hematology/Oncology Division at Columbia University Medical Center. Dr. Lamanna specializes in the treatment of adult patients with acute and chronic leukemias. Her clinical research focus has been the development of combination therapies that include immune-modulatory drugs, kinase inhibitors, bcl-2 inhibitors, monoclonal antibodies as well as new agents in development for this disease. She is a staunch patient advocate and participates regularly in CLL patient advocacy groups with the goal of educating patients about their disease and treatment options. She has lectured and chaired CLL sessions at international and national meetings and has published in various scientific journals, including Blood, Journal of Clinical Oncology, Lancet and The New England Journal of Medicine.